AU2003212509A1 - Compounds for use as surfactants - Google Patents

Compounds for use as surfactants

Info

Publication number
AU2003212509A1
AU2003212509A1 AU2003212509A AU2003212509A AU2003212509A1 AU 2003212509 A1 AU2003212509 A1 AU 2003212509A1 AU 2003212509 A AU2003212509 A AU 2003212509A AU 2003212509 A AU2003212509 A AU 2003212509A AU 2003212509 A1 AU2003212509 A1 AU 2003212509A1
Authority
AU
Australia
Prior art keywords
compounds
surfactants
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212509A
Other languages
English (en)
Inventor
Brian Edgar Looker
Christopher James Lunniss
Alison Judith Redgrave
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003212509A1 publication Critical patent/AU2003212509A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
AU2003212509A 2002-03-06 2003-03-04 Compounds for use as surfactants Abandoned AU2003212509A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0205327.0 2002-03-06
GBGB0205327.0A GB0205327D0 (en) 2002-03-06 2002-03-06 compounds
PCT/GB2003/000876 WO2003074537A1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants

Publications (1)

Publication Number Publication Date
AU2003212509A1 true AU2003212509A1 (en) 2003-09-16

Family

ID=9932460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212509A Abandoned AU2003212509A1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants

Country Status (9)

Country Link
US (1) US7354966B2 (https=)
EP (1) EP1480990B1 (https=)
JP (1) JP2005519119A (https=)
AT (1) ATE309253T1 (https=)
AU (1) AU2003212509A1 (https=)
DE (1) DE60302222T2 (https=)
ES (1) ES2250874T3 (https=)
GB (1) GB0205327D0 (https=)
WO (1) WO2003074537A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53514B1 (sr) * 2009-10-02 2015-02-27 Chiesi Farmaceutici S.P.A. Farmaceutske aerosolne formulacije od formoterola i beklometazon dipropionata
GB201205632D0 (en) * 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
JPH02273536A (ja) * 1989-04-13 1990-11-08 Yakult Honsha Co Ltd 界面活性剤およびその製造法
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
AU654813B2 (en) 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
DE69101639T2 (de) 1990-06-27 1994-10-06 Minnesota Mining & Mfg Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe.
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
CA2085884C (en) * 1990-06-29 2001-12-04 Asit Somani Pressurized hydrofluorocarbon aerosol compositions
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
AP791A (en) 1995-04-14 1999-12-17 Glaxo Wellcome Inc Metered dose inhaler for albuterol.
EP0880530B1 (de) * 1996-02-16 2003-07-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Phosphatidyloligoglycerine
US6451287B1 (en) * 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
GB0205327D0 (en) 2002-04-17
US20050287076A1 (en) 2005-12-29
EP1480990A1 (en) 2004-12-01
JP2005519119A (ja) 2005-06-30
US7354966B2 (en) 2008-04-08
EP1480990B1 (en) 2005-11-09
DE60302222T2 (de) 2006-06-01
DE60302222D1 (de) 2005-12-15
WO2003074537A1 (en) 2003-09-12
ES2250874T3 (es) 2006-04-16
ATE309253T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
AU2003228770A1 (en) Substituted pyrazolopyrimidines
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
PL369530A1 (en) Chemical compounds
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
IL164511A0 (en) Heterocyclic compounds
AU2002239344A1 (en) Pyrazolopyridines
AU2002246728A1 (en) Carboline derivatives
IL164509A0 (en) Furyl compounds
WO2004014893A3 (en) Antimicrobial aza-bicyclic derivates, their compositions and uses
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
IL164613A0 (en) Thienyl compounds
GB0127903D0 (en) Improvements relating to organic compounds
AU2001266575A1 (en) Chemical compounds
AU2003217712A1 (en) Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
AU2002249890A1 (en) Carboline derivatives
AU2003290592A1 (en) Antitumor benzoylsulfonamides
MY133969A (en) Indoloquinazolinones
SE0103710D0 (sv) Compounds
WO2005028474A3 (en) Pyrazoloquinoline derivatives as chk-1 inhibitors
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
MXPA03003942A (es) Compuestos bis-heterociclicos con actividad antitumoral y quimiosensibilizante.
AU7027100A (en) Novel compounds
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase